We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

EU Approves Novartis's laBCC Therapy

News   Aug 24, 2015

 
EU Approves Novartis's laBCC Therapy
 
 
 

RELATED ARTICLES

AI Could Warn About Drug Interaction Side Effects

News

Researchers have designed an algorithm that analyzes data on drug-drug interactions listed in reports — compiled by the Food and Drug Administration and other organizations — for use in a possible alert system that would let patients know when a drug combination could prompt dangerous side effects.

READ MORE

Developing Pioneering Cell Therapies for Immunotherapy Non-responders

News

New research signposts a novel, less invasive method to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to currently-approved immune-based treatments.

READ MORE

Even Short-term Vaping Causes Inflammation in Non-smokers, Says Pilot Study

News

Researchers report the first evidence of biological changes correlated with e-cigarette use in never-smokers.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE